When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Last reviewed: 16 Mar 2025
Last updated: 15 Apr 2025

Summary

Definition

History and exam

Key diagnostic factors

  • presence of risk factors
  • blurred vision and diplopia
  • impaired accommodation
  • ptosis
  • oculobulbar weakness
  • hypoglossal weakness
  • dysarthria
  • dysphagia
  • symmetrical descending flaccid paralysis

Other diagnostic factors

  • hypotonia
  • feeding difficulties in infants
  • weakened cry in infants
  • hypothermia
  • urinary retention
  • constipation
  • dry mouth and throat
  • postural hypotension
  • gastrointestinal illness
  • diminished or absent deep tendon reflexes
  • absence of fever
  • respiratory dysfunction
  • pupillary dilation

Risk factors

  • ingestion of contaminated foods
  • ingestion of honey in infants
  • ingestion of soil in infants
  • intravenous drug use
  • crush injury
  • infant age group
  • abnormal bowel anatomy
  • therapeutic or cosmetic use of botulinum toxin
  • biological terrorism
  • exposure to reptiles

Diagnostic investigations

1st investigations to order

  • mouse bioassay of serum, gastric secretions, stool, or food samples
  • culture of food samples, gastric aspirates, or faecal material

Investigations to consider

  • electrophysiological testing

Emerging tests

  • enzyme-linked immunosorbent assay (ELISA)
  • polymerase chain reaction (PCR)

Treatment algorithm

Contributors

Authors

Linda S. Nield, MD, FAAP
Linda S. Nield

Professor of Pediatrics and Medical Education

West Virginia University School of Medicine

Morgantown

WV

Disclosures

LSN is an author of a reference cited in this topic.

Acknowledgements

Dr Linda S. Nield would like to gratefully acknowledge Dr Thomas P. Bleck, Dr Aimee Hodowanec, Dr Pavani Reddy, and Dr Teresa Zembower, previous contributors to this topic.

Disclosures

TPB, AH, PR, and TZ declare that they have no competing interests.

Peer reviewers

Fiona Cooke, MA, PhD, MSc, FRCPath, MRCP, DTM&H

Research Fellow and Medical Microbiologist

Wellcome Trust Sanger Institute

Department of Microbiology

Addenbrooke's Hospital

Cambridge

UK

Disclosures

FC declares that she has no competing interests.

Christopher D. Huston, MD

Assistant Professor of Medicine

Division of Infectious Diseases

University of Vermont College of Medicine

Burlington

VT

Disclosures

CDH declares that he has no competing interests.

William A. Petri, Jr, MD, PhD, FACP

Chief and Professor of Medicine

Division of Infectious Diseases and International Health

University of Virginia Health System

Charlottesville

VA

Disclosures

WAP declares that he has no competing interests.

Use of this content is subject to our disclaimer